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ABSTRACT 
This paper starts by establishing a prima facie case that disadvantaged groups or 
individuals are not only more likely to get a chronic disease but also in a disadvantaged 
position to adhere to chronic treatment despite access through Universal Health 
Coverage. However, the main aim of this paper is to explore the normative implications 
of this claim by examining two different but intertwined argumentative lines that might 
contribute to a better understanding of the ethical challenges faced by chronic disease 
health policy. The paper develops the argument that certain disadvantages which may 
predispose to illness might overlap with disadvantages that may hinder self-management, 
potentially becoming disadvantages in handling chronic disease. If so, chronic diseases 
may be seen as disadvantages in themselves, describing a reproduction of disadvantage 
amongst the chronically ill and a vicious circle of disadvantage that could both predict 
and shed light on the catastrophic health outcomes amongst disadvantaged groups—or 
individuals—dealing with chronic disease. 
 
INTRODUCTION 
When I worked as a clinical psychologist at the HIV/AIDS polyclinic of a public 
hospital in Santiago, Chile I was confronted with the fact that, on a daily basis, some of 
our patients died despite having access to treatment through Universal Health Coverage 
(UHC). Healthcare professionals would frequently say things like: “Patients have all the 
medical care they need to cope with this disease, if they die it’s because they are silly, 
they do not listen, and do not follow our recommendations”.1  The underlying rationale of 
these statements is that in a context where the state offers free care at the point of access, 
it is the patients’ responsibility to manage their care and thus, their fault if they die from a 
treatable disease. This always struck me as extremely harsh—in the same line of inquiry 
posed by the harshness objection, which is frequently raised against luck egalitarian 
arguments on individual responsibility.1 
HIV/AIDS is a potentially lethal infectious disease, but through highly active 
antiretroviral therapy (HAART) it has become a chronic illness. Evidence shows that low 
rates of adherence to chronic treatment for HIV/AIDS are not just a local challenge in 
Chile,2 but a global problem. A meta-analysis from 2011 synthesising 84 observational 
studies across 20 countries—including Low and Middle-Income Countries (LMICs) as 
well as High-Income Countries (HICs)—showed that the average reported rate of 
satisfactory adherence to HAART was 62%.3 Despite relevant illness-specific 
characteristics, adherence to chronic treatment for all chronic diseases seems to be in 
crisis. The estimates are that adherence to long-term treatment for all chronic diseases is 
only around 50% in HICs and presumably even less in LMICs.4  
The health service I worked for offered care to one of the most disadvantaged 
groups of patients in Santiago and the most important aspect of my job was to support 
and promote adherence to treatment in order to improve patients’ quality of life and 
reduce mortality rates. Through clinical observation I confirmed the association often 																																																								1	These are recollections from my own clinical experience.	
established by researchers studying social determinants of health and chronic illness self-
management: that “the life situation of the patients may determine health outcomes as 
much as the action of healthcare professional and healthcare systems do. Access alone 
does not ensure benefits of available medical services”.5(p406)  
Analysing the experience of chronic illness and the challenges of chronic 
treatment adherence, I identified social isolation and psychological distress as 
fundamental features of my day-to-day work. From a clinical perspective, it seemed that 
these were not only some of the variables that may have predisposed these patients to 
illness in the first place but also relevant disadvantages for adhering to chronic treatment. 
This implies a way of thinking about the relationship between the social determinants of 
health and self-management of chronic illness that could be described—borrowing Wolf 
and de-Shalit’s6 language—as the corrosive effect of certain disadvantages. From an 
ethical perspective, this observation gains significant weight by suggesting that access to 
chronic treatment might be most useful for patients who can successfully self-manage 
their chronic illness, doing little for those who somehow cannot. 
Despite acknowledging the importance of illness-specific variables for self-
management, the focus of this paper is on the common core of self-management for 
chronic illness,7 inviting the reader to think outside the boundaries of biomedical 
diagnostic categories, focusing instead on the temporality that defines them: chronicity. 
This focus is particularly relevant for self-management tasks since these have to be 
indefinitely integrated by the ill subjects, determining their experience of chronic disease 
and its impact on the self.	
The infectious/chronic division in epidemiology comprises an incompatible 
classification system (cause versus effect) and the intersection between the two is a 
neglected area in public health despite the fact that common social determinants underlie 
both.8 Thus, I propose that in present times, focusing on temporality of disease might 
offer a more comprehensive, useful and precise approach than one that conflates 
communicability and temporality.	
The rest of this article develops the thesis that disadvantaged groups or individuals 
are not just more likely to have a chronic disease, but also in a disadvantaged position 
regarding adherence to chronic treatment. By introducing the idea that disadvantages 
predisposing to chronic disease may correlate with disadvantages that hinder self-
management of chronic illness, I will describe a vicious circle of disadvantage affecting 
the chronically ill and suggest that chronic illnesses become risk multipliers for 
disadvantage. 	
 The first section of the article will describe how UHC systems, by mainly 
offering equality of opportunity for healthcare services in contexts of inequality, have 
failed to address the problem of chronic disease health inequalities. I stress the need to 
better understand the mechanisms that link social determinants of health and healthcare 
outcomes. The second section will explore the psycho-emotional impact of chronic 
illness, showing how, from a psychological perspective, it can be particularly challenging 
to indefinitely integrate self-management tasks and adhere to chronic treatment. Finally, 
the third section will aim for an integration of these perspectives, suggesting that there 
are good reasons to think that inequalities in adherence to treatment are correlated with 
and aggravate existing inequalities. Thus, drawing on Wolff and de-Shalit’s6 account of 
disadvantage, this paper proposes a framework for interpreting and responding to 
treatment adherence inequalities in chronic diseases, extending this account by specifying 
their idea of disadvantage for the particular case of chronic illness.  
 
I. EQUALITY OF OPPORTUNITY FOR HEALTHCARE SERVICES AND 
CHRONIC DISEASE  
To better understand equality of opportunity for accessing healthcare services it is 
important to briefly consider the rights framework that supports UHC systems. The 
International Covenant on Economic, Social and Cultural Rights establishes a “right of 
everyone to the enjoyment of the highest attainable standard of physical and mental 
health”,9 but this definition was narrowed down in the General Comment No. 14 and 
operationalized as a “right to a system of health protection which provides equality of 
opportunity for people to enjoy the highest attainable level of health.” That is, a “right to 
the enjoyment of a variety of facilities, goods, services and conditions necessary for the 
realization of the highest attainable standard of health”.10(p3) Thus, the right to health is 
broadly understood in terms of equality of opportunity for accessing healthcare services. 
However, this does not seem to be an adequate response to chronic diseases.	
Noncommunicable chronic diseases are the main cause of death worldwide and, 
every year, almost three-quarters of these deaths occur in LMICs.11 50% of all chronic 
disease deaths are considered premature deaths, and 82% of these premature deaths occur 
in LMICs. Taking into account that approximately 85% of the world’s population 
concentrates in LMICs,12 these statistics broadly show that premature deaths caused by 
chronic diseases represent a significant and similar challenge across the world—in HICs 
and LMICs. Still, the distribution of noncommunicable chronic diseases follows 
Marmot´s13 description of the social gradient of health, meaning that the burden of 
disease for these diseases tends to cluster amongst countries where economic resources 
are scarce and amongst the poor within wealthy societies.11, 14 Although there are no 
global statistics accounting for a category of chronic diseases that includes chronic 
communicable diseases, it could be argued that if statistics for noncommunicable chronic 
diseases were to include those for chronic communicable diseases, the numbers would 
only add to and follow the same pattern of distribution.2 Furthermore, social determinants 
of health such as poor diet, sedentary lifestyle, tobacco and alcohol consumption, and 
social isolation have been identified as significant individual health risk factors for 
chronic disease. All these risks affect individuals from lower socioeconomic levels the 
most, following a gradient across socioeconomic groups.19 Overall, this evidence 
suggests that there is a pattern of unequal distribution of morbidity and mortality of 
chronic diseases in all societies. 
Thus, UHC systems founded on a framework of equal access to healthcare have 
not been enough to improve populations´ health as a whole and thus tackle health 
inequalities.13, 20A well-described and analysed example of this is the United Kingdom´s 
(UK) National Health Service (NHS). After the UK introduced UHC in 1948, inequalities 
both in access to healthcare and in health outcomes across the population persisted. In 
fact, on the whole, the health of individuals from higher socioeconomic levels improved, 																																																								
2  There is a strong association between poverty and poor environmental health and 
infectious diseases.15 E.g. the statistics for HIV, TB and Malaria show that these diseases 
are most prevalent and deadly in disadvantaged contexts.16-18	
while the health of those of lower socioeconomic levels showed small differences.20 This 
is not only explained by the fact that, from a population health level, what makes people 
sick are socioeconomic variables that fall outside healthcare systems, but also because the 
better-off are able to make use of the healthcare services, while the rest of the population 
is not, or at least not in the same way.13, 21  
The fundamental cause theory of health inequalities argues that; knowledge, 
money, power, prestige, and beneficial social connections are key flexible resources that 
influence multiple disease outcomes. Access to these resources can contribute to the 
prevention of diseases and their negative effects, and the flexibility of these resources 
implies that there is a variety of mechanisms through which this can happen.22 This 
complex relationship between social variables and health outcomes has been used to 
argue for a know/do gap which causes clinical outcomes to be uneven and health 
disparities to persist despite effective treatments being available.23 
Thus, it could be argued that, despite UHC, low treatment adherence for chronic 
conditions follows a social gradient that contributes to the unequal distribution of high 
rates of premature deaths and poor individual and population health outcomes 
worldwide.4, 24 Chronic patients are their own principal caregivers, which without 
undermining the importance of contextual variables, leads to the assumption that medical 
care for chronic disease frequently fails to meet different individuals’ needs to effectively 
self-manage their disease.24, 25 Of course, healthcare is still frequently structured around 
acute care, but this does not explain the inequalities in outcomes for people of different 
socioeconomic levels in managing chronic illness.26 This suggests that individuals of low 
socioeconomic level may have disadvantages that preclude them from effectively making 
use of available resources for management of chronic illness and that these disadvantages 
may overlap those which predisposed them to chronic illness in the first place. 
Although the General Comment No. 14 acknowledges that socioeconomic 
inequalities play a role in health and identifies potential issues regarding accessibility,10 
these do not seem to anticipate the possibility that introducing systems based on equality 
of opportunity in unequal contexts might exacerbate existing disadvantages. 
 
II. THE PSYCHO-EMOTIONAL IMPACT OF CHRONIC ILLNESS 
As I have argued, having highly effective treatments available for the 
management of chronic disease is not sufficient for achieving the expected chronic 
disease health outcomes. Improving self-management for chronic illness seems to be the 
key to success, however research shows that although self-management education can 
improve health outcomes to some extent, sustaining these improvements in the long term 
remains a problem.25  
The individual model of self-management has been criticised for focusing 
predominantly on education and advice giving—reproducing a medical model that 
develops dependency on professionals—and paying less attention to the psycho-
emotional issues patients face.25, 27-29 
All chronically ill patients face a common set of challenges, which imply difficult 
lifestyle adjustments. Some of these adjustments include complex medication regimens; 
obtaining helpful medical care; dealing with symptoms, disability, and emotional 
impacts, all of which involve significant psychological processes.24  
It has been argued that in order to move beyond the burden and suffering 
associated with living with chronic diseases and effectively manage their illnesses, 
patients have to face a process of being transformed by the experience, aiming at the 
integration of new ways of being.30 This process of transformation acknowledges to some 
extent the deep challenges that chronic illnesses raise for human subjectivity and identity. 
Bury31 suggests that the experience of chronic illness implies that “the structure of 
everyday life and the forms of knowledge, which underpin them, are disrupted. Chronic 
illness involves recognition of the worlds of pain and suffering, possibly even of death, 
which are normally only seen as distant possibilities or the plight of others […]. Further 
expectations and plans that individuals hold for the future have to be re-examined. Thus, 
chronic illnesses must be regarded as critical situations, a form of biographical 
disruption”.31(p169)  
Hence, chronic illnesses constitute the imposition of an experience that demands 
significant adjustments not only in terms of the day-to-day life, but also in terms of the 
subjectivity and identity built around a healthy self that implies a profound experience of 
loss. Kleinman32 argues that loss of function, self-image, and ways of living, are key 
psychological features of the chronicity of illness. Thus, by losing the healthy self to 
chronic illness, the individual losses the experience of continuity of the self, and of future 
expectations that were enabled by that self.	
This process of subjective transformation has been argued to face significant 
resistance. Relying on a healthy, capable body seems to be part of the rules of the game 
of life, and it is inherent to subjects’ daily experience. Therefore, chronic illness bursts as 
a betrayal of that fundamental trust in the body.32 According to MacIntyre,33 human 
subjectivity seems to be constituted in contrast to its organic composition, by resisting 
and even denying facts of disability and dependence brought by illness. 
A lack of empathy towards this challenging subjective state has been argued to be 
one of the most painful experiences of illness,34 so another central feature of chronic 
illness is that individuals withdraw from social relationships, which leads to growing 
isolation partly because disruptions in biography are disruptions of the ability to mobilise 
material resources.31 This can help explain why being well-supported by friends and/or 
family correlates with greater agency to implement desired health behaviour changes.27  
Integrating these views about the psycho-emotional impact of chronic illness and 
linking them to low treatment adherence rates, I suggest that the lack of empathy might 
not only be experienced in social interactions with healthy people, but also in the 
intimacy of a disrupted subjectivity that has to cope with conflicting selves. A self-
management approach that pays attention to psycho-emotional issues would imply 
understanding that mobilising the resources needed to follow treatment, often requires 
being able to mourn a healthy self—a self that rejects embracing a new self that 
experiences itself in loss, failure, dependency. Negotiating this disruption may be a 
necessary step to build and embrace a new self that is willing to make the effort of 
following treatment, to be subject to invasive interventions, routine check-ups, and more, 
just to keep living or to avoid further disability. 
 
III. THE VICIOUS CIRCLE OF DISADVANTAGE IN THE CHRONICALLY 
ILL 
Taking into account the unequal distribution of chronic illness and the psycho-
emotional challenges raised by chronic illnesses that may hinder successful self-
management of disease, there might be cumulative inequalities that affect the chances of 
successful self-management of chronic illness. Acknowledging this implies that chronic 
illnesses are risk multipliers for disadvantage and that a theory of the ethics of chronic 
disease is required. This section aims to suggest an outline for such a theory. 
Wolff and de-Shalit6 propose a theory in which disadvantage is described as an 
intrinsically plural phenomenon, arguing that when it comes to understanding 
disadvantage, relations of simple direct causation and linearity do not apply. These 
authors’ theory of disadvantage builds on the capabilities approach3 and incorporates the 
notion of functionings, but it proposes a relevant distinction between formal and genuine 
opportunity to achieve functionings to replace the concept of capability or freedom to 
achieve functionings. Thus, whether it is reasonable to expect something from 
individuals, will depend on whether they have a genuine opportunity to achieve it.6  
So, would UHC by itself constitute a genuine opportunity for chronic healthcare? 
And, consequently, would it be reasonable to expect all patients to succeed in self-
managing chronic illness and adhere to treatment regardless of their background and 
circumstances? To answer these questions, I will focus on the functioning of affiliation 
since it has shown to be particularly relevant to better understand chronic patients’ 
difficulties to cope with self-management tasks. 
Having a sense of belonging or affiliation makes reference to the ability to 
develop relationships with others, have people to rely on, feel cultural or class-related 
belonging amongst others, and be loved, liked and thus accepted by others.6 From an 
empirical perspective, affiliation has shown clear elements of clustering with the 
functionings of sense, imagination and thought; control over one’s environment; and 
bodily health, thus working as one of the most fertile functionings, or corrosive 
disadvantages.6 Fertile in the sense that it allows overcoming disadvantage by facilitating 
the achievement of the other functionings, and corrosive in the sense that lacking 
affiliation probably implies lacking all of them.6 Furthermore, all these functionings have 
been argued to correlate with socioeconomic level and follow a gradient amongst 
socioeconomic groups.13 
 In this same line of argument, self-management courses experiences highlight 
that the main variables linked to successful outcomes are associated with creating a social 
context characterized by collaborative coping, shared learning, and belonging, which 
mainly provide a solution to the social isolation experienced by chronically ill 
individuals.27 However, this might be particularly challenging considering that the 
chronically ill  are likely to be the disadvantaged—potentially lacking fucntionings such 
as affiliation and all those clustering with it. Therefore, it seems ethically meaningful to 
consider whether these individuals are in a position of disadvantage to self-manage their 
disease and cope with the psychological features that have been argued to lead to even 
further isolation.  
Following Wolff and de-Shalit’s6 understanding of disadvantage, there are mainly 
two parameters that can determine if individuals have a genuine opportunity to make use 
of healthcare services and adhere to chronic treatment recommendations. These are the 																																																								3	 	See	Nussbaum, M. Women and human development: the capabilities approach. 
Cambridge: Cambridge University Press 2000. 	
cost that achieving one lacking functioning can have over an already achieved 
functioning, which depends on the individual’s already achieved functioning level.6 
Therefore, equality of opportunity for healthcare services might only constitute a genuine 
opportunity for healthcare if everyone enjoys a level of secure central functionings that is 
not jeopardized by making use of healthcare services.  
Since the chronically ill are likely to be disadvantaged in terms of their 
socioeconomic level and the previously described clustering functionings,6, 13, 19 it would 
follow that the chronically ill are unlikely to enjoy a level of secure central functionings 
and therefore, unlikely to have a genuine opportunity to benefit from healthcare services 
despite having access to UHC. This implies that it would not be reasonable to expect 
them to comply with chronic treatment recommendations, suggesting a more complex 
approach to personal responsibility. Furthermore, since chronic illness diagnoses have 
been argued to have a negative impact on relevant functionings for chronic treatment 
adherence such as affiliation, there might be a cumulative effect of disadvantage leading 
to a vicious circle of disadvantage amongst the chronically ill. Furthermore, this implies 
that chronic illness diagnoses become risk multipliers for disadvantage, aggravating 
existing inequalities. 
This brief exercise focused on broad evidence regarding affiliation and social- 
support for successful self-management of chronic illness suggests that the concepts of 
fertile functionings and corrosive disadvantages can be key to tackle the reproduction of 
disadvantage in health. Although Wolff and de-Shalit6 do not present their theory in terms 
of a systems theory, I propose that it could be a useful background to extend the reach of 
Wolff and de-Shalit’s6 work and my own contributions to the ethics of chronic illness.  
In general terms, systems are interconnected sets of elements or stocks aiming for 
a particular goal through balancing feedback loops. Although stocks are the foundation of 
the system and the information flowing through their interconnections is what holds the 
system together, inflows and outflows determine how stocks can change over time. While 
the behaviour of each element may be simple, their interactions will often be complex, 
involving multiple levels of feedback loops that serve to either balance or reinforce the 
behaviours of other parts of the system.35  
Thus, thinking about disadvantage, chronic illness, and chronic treatment 
adherence in terms of interconnected elements in the form of a vicious circle or runaway 
loop of damage, implies adopting a systems theory perspective. From this perspective, the 
assumption that equality of opportunity to access healthcare services implies that 
individuals equally benefit from that opportunity errs in that it ignores the relevance of 
the relationship arising from these interacting elements. As long as there are at least two 
independent processing elements interacting in a system, difference is created; this is new 
information that is immanent in their mutual relationship of double description.36  
If social and psychological resources, chronic illness, and adherence to chronic 
treatment are seen as stocks and flows within a system that seeks to minimise the 
negative effects of chronic illness, we would need to know which are the required inflows 
and outflows of social and psychological resources, and chronic treatment adherence to 
achieve this goal. Paying attention to the information arising from the interaction of these 
stocks—relationships—is the key to achieving dynamic equilibrium.  
I have highlighted affiliation as one possible contextual feature that can contribute 
to a better flow of stocks, promoting the system’s ability to achieve its goal. Thus, 
incorporating the idea of fertile functionings and corrosive disadvantages into a broader 
systems theory approach to healthcare might provide a fruitful framework to better 
understand the mechanisms by which information flows between myriad resources and 
health.  
Although specific empirical investigation is required to identify fertile 
functionings and corrosive disadvantages affecting health outcomes in chronic illness, in 
advance of this enquiry, we know that social and psychological resources are stocks of 
which each person has a different amount before becoming ill and that those having a 
lower stock level are more likely to become chronically ill. Thus, the chronically ill, by 
being likely to have a low stock level of social and psychological resources see their 
chances of producing an outflow of adherence to chronic treatment recommendations 
reduced, leading to a vicious circle that by destroying every little stock available, leads to 
poor health results and further disadvantage.  
 
CONCLUSION 
This paper has argued that there are significant health inequalities that are caused 
—within systems of UHC—by the fact that patients’ abilities to adhere to treatment for 
chronic diseases are widely different. This raises ethical issues relating to patients 
suffering avoidable morbidity and mortality as a result of uncontrolled chronic illness, 
and also because there are good reasons to think that inequalities in adherence to chronic 
treatment are correlated with, and aggravate, existing health inequalities. 
Bioethicists have largely ignored inequalities that arise from differences in 
adherence to chronic treatment. Drawing on Wolff and de-Shalit´s6 account of 
disadvantage, this paper proposes a framework for interpreting and responding to 
treatment adherence differences in chronic diseases, although it extends this account by 
applying their theory of disadvantage to the particular case of chronic illness. Individuals 
living in disadvantage in terms of their socioeconomic level and their achieved 
functionings level might be more likely to: 1) get a chronic illness and live shorter lives; 
2) lack the functionings that could allow them to successfully self-manage their illness; 
and 3) be at risk to become more disadvantaged as a result of chronic illness. 
Although this paper has no intention to dismiss the value of UHC, it does stress 
the need for healthcare systems to go beyond equality of opportunity for access in order 
to become a more effective instrument for distributive justice, highlighting the potential 
of adopting a systems theory perspective to do so. For the particular case of chronic 
illness, the argument of this article supports further empirical research on the key 
functionings that could facilitate better health outcomes for the chronically ill and calls 
for urgent revision of the distribution and compensation of these functionings through the 
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